Pegasus Partners’s Calidi Biotherapeutics CLDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-458
Closed -$31.1K 168
2024
Q1
$31.1K Buy
458
+143
+45% +$9.7K ﹤0.01% 149
2023
Q4
$57.1K Buy
+315
New +$57.1K 0.01% 142